Skip to main content
. 2017 Apr 7;32(1):707–711. doi: 10.1080/14756366.2017.1302440

Figure 2.

Figure 2.

Effect of HBOT on serum RANKL level in ANFH patients. There was no significant change in serum RANK-L levels during HBO treatment, being 318.2 ± 48.66 pmol/L, 347.7 ± 155.40 pmol/L, 299.7 ± 44.36 pmol/L, 303.2 ± 45.89 pmol/L, and 380.5 ± 51.41 pmol/L at T0, T1, T2, T3, and T4, respectively. T0: Baseline, T1: after 12 HBO, T2: after 30 HBO, T3: after 45 HBO, and T4: after 60 HBO.